Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study

[1]  Robin Patel.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Calandra,et al.  Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Bauer,et al.  Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational Study , 2012, PloS one.

[4]  G. Weiss,et al.  Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis , 2012, Wiener klinische Wochenschrift.

[5]  H. Lippert,et al.  PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRS , 2012, Langenbeck's Archives of Surgery.

[6]  T. Welte,et al.  Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view , 2011, Intensive Care Medicine.

[7]  H. Wolf,et al.  Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  M. Tormo,et al.  Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[9]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Becker,et al.  Staphylococcus, Micrococcus, and Other Catalase-Positive Cocci* , 2011 .

[11]  J. Timsit,et al.  Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. , 2010, The Journal of infection.

[12]  T. Calandra,et al.  Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia , 2010, Journal of Clinical Microbiology.

[13]  Rita De Rosa,et al.  MOLECULAR IDENTIFICATION OF BLOODSTREAM PATHOGENS IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH SUSPECTED SEPSIS , 2010, Shock.

[14]  S. Nseir,et al.  Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  M. Vaneechoutte,et al.  Approaches to the identification of aerobic Gram-negative bacteria , 2010 .

[16]  M. Mathru.  Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock , 2010 .

[17]  M. Struelens.  Detection of microbial DNAemia: does it matter for sepsis management? , 2010, Intensive Care Medicine.

[18]  M. Bauer,et al.  A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis , 2010, Intensive Care Medicine.

[19]  L. Lehmann,et al.  Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis , 2009, Critical care medicine.

[20]  Sylvia Siebig,et al.  Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis , 2009, BMC infectious diseases.

[21]  G. Warhurst,et al.  Bench-to-bedside review: The promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection , 2009, Critical care.

[22]  A. Hoeft,et al.  Utility of a Commercially Available Multiplex Real-Time PCR Assay To Detect Bacterial and Fungal Pathogens in Febrile Neutropenia , 2009, Journal of Clinical Microbiology.

[23]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.

[24]  T. Stijnen,et al.  Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. , 2007, The Journal of antimicrobial chemotherapy.

[25]  Thomas Emrich,et al.  A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples , 2008, Medical Microbiology and Immunology.

[26]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[27]  A. Sharma,et al.  Febrile neutropenia in haematological malignancies. , 2005, Journal of postgraduate medicine.

[28]  D. Maki,et al.  Infections in the neutropenic patient--new views of an old problem. , 2001, Hematology. American Society of Hematology. Education Program.

[29]  Henry D. Isenberg,et al.  Manual of Clinical Microbiology , 1991 .

[30]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[31]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.